|
|
|
Insider
Information: |
Szyman Catherine M |
Relationship: |
Director |
City: |
Minneapolis |
State: |
MN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
123,190 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,365,284 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
123,190 |
|
|
Total
Value |
$2,365,284 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
4
|
Stock
price went up :
|
0
|
4
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
Percentage
Gain/Loss : |
0.0%
|
55.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Edwards Lifesciences Corp |
EW |
CVP, Critical Care |
2024-05-11 |
76,165 |
2019-08-30 |
0 |
Premium* |
|
Inari Medical, Inc. |
NARI |
Director |
2024-04-24 |
22,429 |
2020-05-27 |
0 |
Premium* |
|
Outset Medical, Inc. |
OM |
Director |
2023-05-31 |
24,596 |
2021-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
157 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NARI |
Inari Medical, Inc. |
Director |
|
2024-04-24 |
4 |
A |
$42.41 |
$174,984 |
D/D |
4,126 |
22,429 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-08-13 |
4 |
AS |
$78.24 |
$175,962 |
D/D |
(2,249) |
26,746 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-03-23 |
4 |
AS |
$162.95 |
$181,852 |
D/D |
(1,116) |
15,773 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2021-05-11 |
4 |
D |
$90.40 |
$183,331 |
D/D |
(2,028) |
28,484 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2023-06-13 |
4 |
OE |
$36.75 |
$183,750 |
D/D |
5,000 |
40,056 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2023-07-10 |
4 |
OE |
$36.75 |
$183,750 |
D/D |
5,000 |
39,814 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2023-08-09 |
4 |
OE |
$36.75 |
$183,750 |
D/D |
5,000 |
39,814 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2023-09-08 |
4 |
OE |
$36.75 |
$183,750 |
D/D |
5,000 |
39,814 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2023-10-10 |
4 |
OE |
$36.75 |
$183,750 |
D/D |
5,000 |
39,814 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-05-14 |
4 |
D |
$178.17 |
$189,929 |
D/D |
(1,066) |
21,768 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2023-05-07 |
4 |
D |
$88.74 |
$191,146 |
D/D |
(2,154) |
29,907 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2021-05-28 |
4 |
AS |
$95.29 |
$196,393 |
D/D |
(2,061) |
27,705 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-02-21 |
4 |
AS |
$176.34 |
$202,086 |
D/D |
(1,146) |
22,601 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-03-15 |
4 |
AS |
$179.10 |
$205,249 |
D/D |
(1,146) |
21,455 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-06-14 |
4 |
AS |
$184.55 |
$211,494 |
D/D |
(1,146) |
19,476 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2021-09-08 |
4 |
OE |
$21.76 |
$211,964 |
D/D |
9,741 |
37,156 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2021-10-18 |
4 |
OE |
$21.76 |
$211,964 |
D/D |
9,741 |
37,156 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2021-11-18 |
4 |
OE |
$21.76 |
$217,600 |
D/D |
10,000 |
37,415 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2021-12-17 |
4 |
OE |
$21.76 |
$217,600 |
D/D |
10,000 |
37,415 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2022-01-14 |
4 |
OE |
$21.76 |
$217,600 |
D/D |
10,000 |
37,415 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-04-15 |
4 |
AS |
$192.00 |
$220,032 |
D/D |
(1,146) |
20,358 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2019-07-15 |
4 |
AS |
$191.70 |
$220,838 |
D/D |
(1,152) |
18,382 |
0 |
- |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-06-16 |
4 |
AS |
$70.67 |
$236,603 |
D/D |
(3,348) |
31,216 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-05-14 |
4 |
AS |
$212.69 |
$237,362 |
D/D |
(1,116) |
12,271 |
0 |
% |
|
EW |
Edwards Lifesciences Corp |
CVP, Critical Care |
|
2020-04-16 |
4 |
AS |
$216.91 |
$242,072 |
D/D |
(1,116) |
14,755 |
0 |
% |
|
157 Records found
|
|
Page 4 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|